A Post-Marketing Observational Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatment of Advanced Prostate Cancer
Observational Model: Case-Only, Time Perspective: Prospective
Effectiveness Parameter for Staging of Prostate Cancer: Metastases at Each Visit
The number of participants with metastases that are absent, local tumor, single metastases, multiple metastases in 1 organ, and multiple metastases in multiple organs at each visit is summarized.
time 0 (Baseline), month 3, and every 3 months until disease progression or up to 24 months, whichever came first
Belgium: Institutional Review Board